Page last updated: 2024-09-03

galactosyl-(1-3)galactose and Leishmaniasis, American

galactosyl-(1-3)galactose has been researched along with Leishmaniasis, American in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bates, MD; Bates, PA; de Souza, LMB; Petterle, RR; Thomaz Soccol, V1
Candela, M; Caniglia, ML; Gabrielli, A; Ricciatti, AM; Wieslander, J1

Trials

1 trial(s) available for galactosyl-(1-3)galactose and Leishmaniasis, American

ArticleYear
Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes.
    Clinical and experimental immunology, 1991, Volume: 86, Issue:3

    Topics: Disaccharides; Enzyme-Linked Immunosorbent Assay; Epitopes; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Laminin; Leishmaniasis, Cutaneous; Radioimmunoassay; Scleroderma, Systemic

1991

Other Studies

1 other study(ies) available for galactosyl-(1-3)galactose and Leishmaniasis, American

ArticleYear
Analysis of Leishmania mimetic neoglycoproteins for the cutaneous leishmaniasis diagnosis.
    Parasitology, 2018, Volume: 145, Issue:14

    Topics: Antibodies, Protozoan; Antigens, Protozoan; Cohort Studies; Disaccharides; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Glycoproteins; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Trisaccharides

2018